Home > News > Plethora shops around for drug delivery platforms
June 22nd, 2006
Plethora shops around for drug delivery platforms
Abstract:
In the first agreement, London-based Plethora will obtain a global exclusive licence to Maelor's micelle nanotechnology, for application in Plethora's PSD597 programme for the treatment of interstitial cystitis and painful bladder syndrome (IC/PBS).
Source:
in-pharmatechnologist.com
Bookmark:
| Related Links |
| Related News Press |
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||